ORLANDO, Fla. (AP) -- A new study raises fresh concerns about Zetia and its cousin, Vytorin - drugs that are still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work....
Study raises new questions about Merck pill ZetiaCourtesy Headlines from the Associated Press Sun, 11/15/2009 - 17:16
ORLANDO, Fla. (AP) -- A new study raises fresh concerns about Zetia and its cousin, Vytorin - drugs that are still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work.... Tags:
More related itemsStudy: No proof of Vytorin link to cancer
Dems Question Timing of Vytorin Papers
Doctors Wary After Cholesterol Drug Flop
|
Popular by tags WeekMonth |
Post new comment